Ticagrelor Versus Cilostazol in Ischemic Stroke
A phase 3 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 900 participants.
Also called NCT06561867
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; double masking; primary purpose treatment
- Phase
- Phase 3
- Enrolled
- 900 participants
- Sponsor
- Registry
-
NCT06561867
-
- Planned start
- (anticipated)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- Egypt
- Registry status
- Unknown status
Technical summary
Registry record NCT06561867. Randomized; double masking; primary purpose treatment. Start 2024-08-30 (anticipated); primary completion 2025-11-30 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Ticagrelor Versus Cilostazol in Ischemic Stroke
- Condition
- Ischemic Stroke
- Intervention (Drug)
- Ticagrelor 90 MG
- Intervention (Drug)
- Cilostazol 100 MG
- Lead sponsor
- Kafrelsheikh University
Record details
- Record id
cardio:ct-nct06561867- Content hash
055e13eab9a54709a9d1c499b44509839bee43a09de2a165b5e45cfbe96ff1d0